Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK: Response to Roze et al. [4]

Diabetic Medicine

Volumn 23, Issue 6, 2006, Pages 709-

  DeVries, J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ECONOMIC EVALUATION; HEALTH ECONOMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; TREATMENT OUTCOME;

EID: 33744787122     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01853.x     Document Type: Letter

References (12)

1. Roze S Valentine WJ Zakrzewska KE Palmer AJ. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Diabet Med 2005 22 : 1239 1245.
2. Weissberg-Benchell J Antisdel-Lomaglio J Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003 26 : 1079 1087.
3. DeVries JH Heine RJ. Insulin pump therapy: a meta-analysis: response to Weissberg-Benchell et al. Diabetes Care 2003 26 : 2485 2486.
4. DeVries JH Snoek FJ Kostense PJ Heine RJ. Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial - mechanisms and implications. Diabetes Metab Res Rev 2003 19 : 357 362.
5. Weissberg-Benchell J Antisdel-Lomaglio J Seshadri R. Insulin pump therapy: a meta-analysis: response to DeVries et al. Diabetes Care 2003 26 : 2485 2486.
6. Pickup J Mattock M Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br Med J 2002 324 : 1 5.
7. Siebenhofer A Plank J Berghold A Horvath K Sawicki PT Beck P et al. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia 2004 47 : 1895 1905.
8. Retnakaran R Hochman J DeVries JH Hanaire-Broutin H Heine RJ Melki V et al. Continuous subcutaneous insulin infusion vs multiple daily injections. The impact of baseline A1c. Diabetes Care 2004 27 : 2590 2596.
9. Doyle EA Weinzimer SA Steffen AT Ahern JA Vincent M Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004 27 : 1554 1558.
10. Hirsch IB Bode BW Garg S Lane WS Sussman A Hu P et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005 28 : 533 538.
11. Bolli GB Capani F Home PD Kerr D Thomas R Torleone E et al. Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomized, open, parallel study. Diabetes 2004 53 : A107 A108.
12. Retnakaran R DeVries JH Hanaire-Broutin H Heine RJ Melki V Zinman B. Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care 2005 28 : 1835 1836.